Phase 2 Vasculitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 50 years old or older and your doctor suspects you may have Giant Cell Arteritis (GCA), a condition causing inflammation of the arteries
- If you are a woman who could become pregnant, you must have a negative pregnancy blood test at the first visit
- You are able to understand what the study involves and are willing to sign a consent form agreeing to take part
- You are willing and able to follow all the steps and procedures required by the study
Who may not be able to join:
- You have low levels of folate (a type of B vitamin) in your body
- You are pregnant, breastfeeding, or planning to become pregnant during the study or within 30 days after the last dose of the study medicine
- You are currently taking certain medicines that lower folic acid levels, such as methotrexate, pemetrexed, or raltitrexed
- You have received a glucose (sugar) drip or nutrition through a drip within 6 hours before the scan
- Your blood sugar level is too high at the time of the scan (confirm with trial site)
- You are unable to stay inside the PET/CT scanning machine for the full length of the scan
- You are unable to lie still for about 45 minutes
- You are unable to avoid eating or drinking (other than water) for 6 hours before receiving the imaging substance used in the scan
- You have had a PET scan within the last 60 days before the study begins
- You have taken vitamin supplements containing more than 1mg per day of folic acid within 48 hours before your scan
- You have a known allergy or sensitivity to folic acid
- You are a close family member, employee, or dependent of one of the researchers running the trial
- You are currently taking part in another clinical trial involving an experimental medicine, or have done so within the 7 days before joining this study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Britta Maurer, Department of Rheumatology and Immunology, Inselspital, University of Bern, Bern, Switzerland
Phone: +41 31 63 2 7229
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Specificity of the GCA-diagnosis at the patient level
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.